# EDGAR Filing Document

**Accession Number:** 0001873875
**File Stem:** 0000000000-23-002260
**Filing Date:** 2023-3
**Character Count:** 3347
**Document Hash:** 8ec2b579e6c5caf4a615f22a0f067f45
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-002260.hdr.sgml**: 20230411

**ACCESSION NUMBER**: 0000000000-23-002260

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230308

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Incannex Healthcare Ltd
- **CENTRAL INDEX KEY:** 0001873875
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** C3
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 401 DOCKLANDS DRIVE
- **STREET 2:** SUITE 15, LEVEL 12
- **CITY:** DOCKLANDS, VICTORIA
- **STATE:** C3
- **ZIP:** 3008
- **BUSINESS PHONE:** 61 409 840 786

**MAIL ADDRESS:**
- **STREET 1:** 401 DOCKLANDS DRIVE
- **STREET 2:** SUITE 15, LEVEL 12
- **CITY:** DOCKLANDS, VICTORIA
- **STATE:** C3
- **ZIP:** 3008
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001213900-23-016745

## Text-Extract

```

United States securities and exchange commission logo

                          March 8, 2023

       Joel Latham
       Managing Director & CEO
       Incannex Healthcare Ltd
       Suite 105, 8 Century Circuit
       Norwest, NSW 2153, Australia

                                                        Re: Incannex Healthcare
Ltd
                                                            Registration
Statement on Form F-3
                                                            Filed March 2, 2023
                                                            File No. 333-270218

       Dear Joel Latham:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Arzhang
Navai at 202-551-4676 with any questions.

                          Sincerely,

                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Andrew Reilly

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

DIVISION OF
CORPORATION FINANCE

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

March 8, 2023

Joel Latham
Managing Director & CEO
Incannex Healthcare Ltd
Suite 105, 8 Century Circuit
Norwest, NSW 2153, Australia

**Re: Incannex Healthcare Ltd**
**Registration Statement on Form F-3**
**Filed March 2, 2023**
**File No. 333-270218**

Dear Joel Latham:

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Arzhang Navai at 202-551-4676 with any questions.

Sincerely,

Division of Corporation Finance
Office of Life Sciences

cc: Andrew Reilly